INTO GERMANY! The German Business Podcast

After the success of previously unknown biopharma company BioNTech in combatting Covid, Germany is back in the spotlight as “the world’s pharmacy.” But what comes next for the sector? And how can international health-sector companies profit? We talk to the world’s oldest pharmaceutical company Merck, a serial entrepreneur and a biotech journalist about personal medication, international partnerships and mRNA technology and its potential for fighting cancer.

Our guests

Laura Matz is the Chief Science and Technology Officer for Merck, Darmstadt, Germany. An executive vice-president, she’s responsible for the corporate innovation teams including the digital office and new digital business models. She has 20 years of experience in semiconductor manufacturing and a decade of experience running semiconductor materials businesses. She has a PhD in analytical chemistry from Washington State University.

Maike Becker-Krüger studied International Relations at Lake Forest College in Chicago and at Franklin University in Switzerland. This was followed by an MBA from Quadriga University Berlin. She worked directly for state premier of the regional German state of Hessen before taking responsibility for European policy coordination within the national government. Starting in 2015, she has built up the capital city office and the Corporate and Government Relations Berlin department at Merck. Since 2022, Maike Becker-Krüger has been Head of EU & Germany Corporate Affairs.

Oliver Schacht is a corporate finance professional and expert in the molecular diagnostics industry and CEO of OpGen. He has co-founded several start-up companies in biotech, clean tech, IT and education in Europe and the US and has experience in developing and implementing commercial strategies and financing measures (including two IPOs). He also serves as the chairman of the Board of Internal Council of Biotechnology Assocations and the president of the German industry association BIO Deutschland. He studied European Business Administration in Reutlingen and London and holds a PhD from Cambridge University (UK).

Dr. Georg Kääb studied biology in Regensburg and Munich and earned his doctorate in neuroimmunology. After freelancing for the Süddeutsche Zeitung newspaper, he became editor-in-chief and co-managing director at the Association of German Biologists. From 2007 to 2021, he headed the communication of the cluster organization BioM (Martinsried), was managing director of the Biotechnology Cluster Bavaria and spokesperson for BioRegions in Germany. Since autumn 2021, he has headed the editorial team of the biotechnology magazine division at media company BIOCOM AG.

Send your feedback and comments to [email protected].

Think Germany, and you probably don’t think fun and games. But you should. Where else is gaming a special part of the Economics Ministry? Germans are absolutely fanatics for games and represent Europe’s biggest electronic gaming market, with some 49 million active players. To get the latest on this dynamic sector, we talk to one of Europe’s leading games developers and the head of the German Association for the Games Industry.

Our guests Benedikt Grindel is managing director of Ubisoft Blue Byte and also heads Ubisoft Düsseldorf. Grindel studied mathematics with a minor in business administration at the University of Münster. He joined Ubisoft in 1998 and worked for three years in the marketing and business development department. He then moved to the game development studio Blue Byte after it was acquired by Ubisoft. As a producer, he was responsible for the "The Settlers" brand, and in 2010 he launched the live operation unit at Ubisoft Blue Byte. In 2014, he took on the role of managing director. Felix Falk has been managing director of game since February 1, 2018. From 2009 to 2016, he was managing director of the Entertainment Software Self-Regulation Body (USK). As vice chairman of the International Age Rating Coalition (IARC), he helped develop the global labeling standard for online games and apps during this time. From 2004 to 2009, he headed the office of Monika Griefahn, chair of the Committee for Culture and Media in the German Bundestag. In this capacity, he was responsible for the computer games and, among other things, helped create the the German Computer Game Prize, which was awarded for the first time in 2009. Send your feedback and comments to [email protected].

R&D in Germany has a long tradition. Its prestigious research institutes are known across the world. And no other European country invests more money in research and development – around 130 billion euros across all sectors in the last year for which figures are available. But part of Germany’s strength is its relatively decentralized, bottom-up orientation. A leader from Germany’s Ministry of Education and Research and a neurologist turned entrepreneur explain what makes R&D in Germany so special.

Our guests:

Professor Thomas Fritz leads the research group “Music Evoked Brain Plasticity“ at the Department of Neurology at the Max Planck Society. His research led him to the foundation of Jimmyn – a start-up based on a software that enables the conversion of bodily movements into music.

Armin Reinartz is Head of the Directorate-General “European and International Cooperation” at the German Federal Ministry of Education and Research.

GDP may have stagnated, foreign direct investment continued apace in Europe’s largest economy. 2024 was a banner year for German pharma and artificial intelligence. The world’s largest IT companies invested heavily in data centers, and the government further relaxed entry regulations for international professionals with sought-after skills and launched massive infrastructure projects to provide the country with green energy. INTO GERMANY looks back at the year that was.

Our guests: Our year in review features leaders from business and politics and Germany Trade & Invest experts from a variety of fields.

Germans may have taken a while to get used to cashless payment systems and other fintech applications, but they’re now rapidly becoming standard in both B2B and B2C. Where are the greatest opportunities and what does the future ho0ld in store? We speak to the head of Berlin’s new fintech hub and the strategy guru at a French neobank that has branched out to Germany.

Our guests: Sebastian Schäfer is an experienced entrepreneur and ecosystem builder and CEO at the newly established HoFT, the House of Finance and Tech in Berlin. Founded in spring 2024, it serves as a central hub within the city’s finance and tech ecosystem. Albertine Lecointe is Vice President of Strategy and Head of Strategic Management at French neobank Qonto, which expanded to Germany in 2020.